SEARCH

SEARCH BY CITATION

References

  • 1
    Crowther MA, Ginsberg JS. Antiphospholipid antibody syndrome. In: GoldhaberSZ, RidkerPM, eds. Thrombosis and Thromboembolism Vol. 44 of Fundamental and Clinical Cardiology. New York: Marcel Dekker, 2002: 4966.
  • 2
    Khamastha MA, Cuadrado MJ, Mujic F, Taub NA, Hung BJ, Hughes GRV. The management of thrombosis in the antiphospholipid syndrome. N Engl J Med 1995; 332: 9937.
  • 3
    Rosove MH, Petronella MC, Brewer PMC. Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients. Ann Interm Med 1992; 117: 3038.
  • 4
    Ruiz-Irastorza G, Hramashta MA, Hung BJ, Escurdero A, Cuadrado MJ, Hughes GRV. Bleeding and recurrent thrombosis in definite antiphospholipid syndrome. Arch Intern Med 2002; 162: 11649.
  • 5
    Palareti G, Leali N, Coccheri S, Poggi M, Manotti C, D'Angelo A, Pengo V, Erba N, Moia M, Ciavarella N, Devoto G, Berrettini M, Musolesi S. Bleeding complications of oral anticoagulants treatment: an inception-cohort, prospective collaborative study (ISCOAT): Italian study on complications of oral anticoagulant therapy. Lancet 1996; 348: 4238.
  • 6
    Odean A, Fahlen M. Oral anticoagulation and risk of death: a medical record linkage study. BMJ 2002; 325: 10735.
  • 7
    Crowther MA, Ginsberg JS, Julian J, Math M, Denburg J, Hirsh J, Douketis J, Laskin C, Fortin P, Anderson D, Kearon C, Clarke A, Geerts W, Forgie M, Green D, Costantini L, Yacura W, Wilson S, Gent M, Kovacs M. A comparison of two intensities of Warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome. N Engl J Med 2003; 349: 11338.
  • 8
    Buller HR, Giancarlo A, Huss RD, Hyers TM, Prins MH, Raskob GE. Antithrombotic therapy for venous thromboembolic disease. Chest 2004; 126: 3.
  • 9
    Finazzi G, Marchioli R, Brancaccio V, Schinco P, Wisloff F, Musial J, Baudo F, Berrettini M, Testa S, D'Angelo A, Tognoni G, Barbui T. A randomized clinical trail of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS). J Thromb Haemost 2005; 3: 84853.